Neuropsychiatric Aspects of Alzheimer Dementia From Mechanism to Treatment

被引:4
作者
Nowrangi, Milap A. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
[2] Johns Hopkins Bayview Med Ctr, Dept Psychiat, 5300 Alpha Commons Dr,4th Floor, Baltimore, MD 21224 USA
关键词
Dementia; Alzheimer; Behavior; Neuropsychiatric; Agitation; Depression; Apathy; MILD BEHAVIORAL IMPAIRMENT; COGNITIVE IMPAIRMENT; RATING-SCALE; DISEASE; SYMPTOMS; APATHY; METHYLPHENIDATE; DEPRESSION; INVENTORY; RISK;
D O I
10.1016/j.psc.2020.02.012
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Developing disease-modifying treatments for Alzheimer dementia requires innovative approaches to identify novel biological targets during the course of the disease. Treatment development for the neuropsychiatric symptoms of Alzheimer may benefit from a mechanistic approach to treatment. There has been progress in identifying mild forms of behavioral impairment along the Alzheimer spectrum that may lead to additional insights into progression to dementia as well as the fundamental mechanisms of the symptoms. Developing therapies for complex neurobehavioral syndromes may require the translation of mechanistic insights into therapy, which may both improve the symptoms and delay progression to dementia in certain patients.
引用
收藏
页码:383 / 397
页数:15
相关论文
共 91 条
[1]   2018 Alzheimer's disease facts and figures [J].
不详 .
ALZHEIMERS & DEMENTIA, 2018, 14 (03) :367-425
[2]   Structural correlates of apathy in Alzheimer's disease [J].
Apostolova, Liana G. ;
Akopyan, Gohar G. ;
Partiali, Negar ;
Steiner, Calen A. ;
Dutton, Rebecca A. ;
Hayashi, Kiralee M. ;
Dinov, Ivo D. ;
Toga, Arthur W. ;
Cummings, Jeffrey L. ;
Thompson, Paul M. .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (02) :91-97
[3]   Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer's disease: a review of 20 years of research [J].
Boublay, N. ;
Schott, A. M. ;
Krolak-Salmon, P. .
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 (10) :1500-1509
[4]   Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimers disease [J].
Bruen, Peita D. ;
McGeown, William J. ;
Shanks, Michael F. ;
Venneri, Annalena .
BRAIN, 2008, 131 :2455-2463
[5]  
Buller Emmali, 2019, Kans J Med, V12, P136
[6]  
Carter MM, 2019, BMJ CASE REP, V12
[7]   Pharmacological Treatment of Depression in Alzheimer's Disease: A Challenging Task [J].
Cassano, Tommaso ;
Calcagnini, Silvio ;
Carbone, Antonio ;
Bukke, Vidyasagar Naik ;
Orkisz, Stanislaw ;
Villani, Rosanna ;
Romano, Adele ;
Avolio, Carlo ;
Gaetani, Silvana .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[8]   Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline [J].
Cintoli, Simona ;
Radicchi, Claudia ;
Noale, Marianna ;
Maggi, Stefania ;
Meucci, Giuseppe ;
Tognoni, Gloria ;
Bonuccelli, Ubaldo ;
Sale, Alessandro ;
Berardi, Nicoletta ;
Maffei, Lamberto .
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 33 (05) :1249-1257
[9]   Profile of mild behavioral impairment and factor structure of the Mild Behavioral Impairment Checklist in cognitively normal older adults [J].
Creese, Byron ;
Griffiths, Alys ;
Brooker, Helen ;
Corbett, Anne ;
Aarsland, Dag ;
Ballard, Clive ;
Ismail, Zahinoor .
INTERNATIONAL PSYCHOGERIATRICS, 2020, 32 (06) :705-717
[10]   Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults [J].
Creese, Byron ;
Brooker, Helen ;
Ismail, Zahinoor ;
Wesnes, Keith A. ;
Hampshire, Adam ;
Khan, Zunera ;
Megalogeni, Maria ;
Corbett, Anne ;
Aarsland, Dag ;
Ballard, Clive .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 27 (08) :823-834